{"id":4854,"date":"2019-11-19T19:43:44","date_gmt":"2019-11-19T10:43:44","guid":{"rendered":"http:\/\/163.180.4.222\/lab\/?p=4854"},"modified":"2019-11-19T19:43:44","modified_gmt":"2019-11-19T10:43:44","slug":"got-mutation-base-editors-fix-genomes-one-nucleotide-at-a-time","status":"publish","type":"post","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=4854","title":{"rendered":"Got mutation? \u2018Base editors\u2019 fix genomes one nucleotide at a time"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h5>A new class of CRISPR-based tools efficiently corrects point mutations in cell lines, animal models and perhaps the clinic.<\/h5>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div class=\"article__body serif cleared\">\n<figure class=\"figure\">\n<div class=\"embed intensity--high\">\n<div class=\"embed intensity--high\"><img decoding=\"async\" class=\"figure__image\" src=\"https:\/\/media.nature.com\/w800\/magazine-assets\/d41586-019-03536-x\/d41586-019-03536-x_17373716.jpg\" alt=\"Genetic engineering and gene manipulation concept, 3d rendering, conceptual image.\" data-src=\"\/\/media.nature.com\/w800\/magazine-assets\/d41586-019-03536-x\/d41586-019-03536-x_17373716.jpg\" \/><\/div>\n<\/div><figcaption>\n<p class=\"figure__caption sans-serif\">Credit: Getty<\/p>\n<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>When Xingxu Huang began thinking about correcting disease-causing mutations in the human genome, his attention turned naturally to CRISPR\u2013Cas9. But it quickly became clear that the popular gene-editing tool wasn\u2019t ideal for the majority of human disease mutations, which result from errors in single DNA nucleotides known as point mutations. More than 31,000 such mutations in the human genome are known to be associated with human genetic diseases. But CRISPR is not particularly efficient at correcting them.<\/p>\n<p>Then Huang learnt about base editors, a new class of genome-modifying proteins that excel at single-site mutations.<\/p>\n<p>Base editors chemically change one DNA base to another without completely breaking the DNA backbone. The first cytosine base editor (CBE), which chemically converts a cytosine\u2013guanine (C\u2013G) base pair into a thymine\u2013adenine (T\u2013A) base pair at a targeted genomic location, was developed in 2016 by chemical biologists David Liu and Alexis Komor at Harvard University in Cambridge, Massachusetts<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR1\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">1<\/a><\/sup>. Another researcher in Liu\u2019s laboratory, Nicole Gaudelli, developed the first adenine base editor (ABE) a year later<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR2\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">2<\/a><\/sup>; it chemically transforms A\u2013T to G\u2013C base pairs.<\/p>\n<p>\u201cBase editing gives very, very good efficiency, about 40\u201350% efficiency for cell lines,\u201d says Huang, a geneticist at ShanghaiTech University in China. \u201cThat\u2019s very high efficiency compared with traditional genome editing,\u201d which is only one-tenth as efficient, he says.<\/p>\n<p>But base editors are not just more efficient than CRISPR\u2013Cas9; they also cause fewer errors. CRISPR\u2013Cas9 acts as molecular scissors that cut both strands of DNA. As the cell repairs the break, random bases can be inserted or deleted (indels), altering the gene sequence. Large chromosomal segments might even be deleted or rearranged. By altering just a specific nucleotide without making double-stranded breaks, base editors cause fewer unwanted mistakes.<\/p>\n<p>Researchers have applied these tools across the evolutionary tree, from bacteria and yeast to rice, wheat, zebrafish, mice, rabbits and monkeys. They have used them to knock out genes, and to create and correct animal models. They have applied them in very early human embryos in the laboratory. And they might one day use base editors to treat human genetic diseases.<\/p>\n<p>&nbsp;<\/p>\n<aside class=\"recommended pull pull--left sans-serif\" data-label=\"Related\"><a href=\"https:\/\/www.nature.com\/articles\/d41586-018-05736-3\" data-track=\"click\" data-track-label=\"recommended article\"><img decoding=\"async\" class=\"recommended__image\" src=\"https:\/\/media.nature.com\/w400\/magazine-assets\/d41586-019-03536-x\/d41586-019-03536-x_17391822.jpg\" \/><\/a><\/p>\n<p class=\"recommended__title serif\">CRISPR gene editing produces unwanted DNA deletions<\/p>\n<\/aside>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>First, however, researchers have to overcome some key hurdles. Like CRISPR\u2013Cas9, base editors sometimes edit sites other than their target. They are limited in which genomic regions they can edit and what base conversions they can perform. And if they are ever to be used in the clinic, researchers will have to get better at delivering them into tissues.<\/p>\n<p>But improved editors are being developed at a rapid rate. \u201cIt\u2019s really a testament to how fast researchers have made progress in the field that we now have dozens of base editors that offer expanded targeting scope, improved DNA specificity and reduced off-target activity,\u201d says Liu. His base-editor constructs have been sent out to more than 1,000 laboratories around the world, he says, and new papers that use these and related tools appear almost weekly.<\/p>\n<p>&nbsp;<\/p>\n<p><b>Building an editor<\/b><\/p>\n<p>To create the first base editor, Komor took advantage of a naturally occurring enzyme called APOBEC1. This enzyme, which is part of the cytidine deaminase family, chemically converts C to uracil (U), an analogue of T that occurs in RNA. Komor fused rat APOBEC1 to a catalytically impaired Cas9 nuclease that is unable to create DNA double-strand breaks. When a guide RNA directs the APOBEC1\u2013Cas9 fusion protein to a target site, the deaminase converts C to U. The cell\u2019s DNA-repair system then fixes the resulting U\u2013G mismatch by converting it into a U\u2013A base pair, and ultimately to a T\u2013A pair.<\/p>\n<p>Additional refinements improved the protein\u2019s efficiency: these included swapping Cas9 for a Cas9 \u2018nickase\u2019 that cuts the G-containing strand, thus nudging the cell to replace the G rather than the U when repairing the U\u2013G mismatch. \u201cThat extra modification boosted our efficiencies up to levels that we were happy with,\u201d says Komor, who is now at the University of California, San Diego. Dubbed BE3, the resulting protein edits cellular DNA with almost a tenfold higher efficiency than CRISPR\u2013Cas9 and with less than 1% indel formation.<\/p>\n<p>The first ABE was tougher to crack. No known naturally occurring enzymes could chemically convert A to G in DNA. \u201cIt was a pretty big ask to create an enzyme that didn\u2019t exist and have it work very well,\u201d Gaudelli says. Luckily for her, Liu\u2019s lab had expertise in using microbes to achieve the rapid directed evolution of proteins. Over seven rounds of evolution and protein engineering, Gaudelli gradually coaxed a bacterial enzyme called TadA, which converts A to G in some RNAs, to accept a DNA substrate and work better in mammalian cells, producing an editor called ABE7.10.<\/p>\n<p>Although they can effect only a subset of possible nucleotide changes, such enzymes can already address the majority of disease-causing point mutations in humans, at least in theory. \u201cThe adenine base editor, in particular, corrects the most common kind of point mutation in humans,\u201d says Liu, referring to G\u2013C to A\u2013T mutations, which account for about half of all known pathogenic single-nucleotide changes. For the moment, however, the technology is for laboratory use only.<\/p>\n<p>&nbsp;<\/p>\n<p><b>Correcting and creating mutations<\/b><\/p>\n<p>In initial studies, Liu\u2019s team showed that CBEs could correct point mutations associated with Alzheimer\u2019s disease and cancer<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR1\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">1<\/a><\/sup>\u00a0in mouse and human cell lines with an on-target editing efficiency of 35\u201375% and a 5% indel rate, compared with CRISPR\u2013Cas9\u2019s 0.1\u20130.3% efficiency and 26\u201340% rate of indel formation. Using ABEs, Liu\u2019s team corrected point mutations responsible for a life-threatening blood-cell disorder called hereditary haemochromatosis, as well as sickle-cell anaemia<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR2\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">2<\/a><\/sup>.<\/p>\n<p>Researchers have used base editors to create and correct animal models of human diseases, including Duchenne muscular dystrophy<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR3\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">3<\/a><\/sup><sup>\u2013<\/sup><sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR5\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">5<\/a><\/sup>, progeria<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR3\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">3<\/a><\/sup>\u00a0and age-related macular degeneration (H. Yang, unpublished observations). \u201cWith base editors, it\u2019s easy to create an animal model and explore pathogenic mutations all over the genome,\u201d says Huang, who has generated mouse models of diseases such as androgen insensitivity syndrome and syndactyly, a condition in which multiple fingers or toes are fused together<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR6\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">6<\/a><\/sup>. Huang was even able to combine CBEs and ABEs in the same mouse embryos, resulting in simultaneous A\u2013G and C\u2013T edits, a trick he achieved using editors with different sequence preferences. \u201cWe can handle several mutations simultaneously and with very high efficiencies,\u201d he says.<\/p>\n<p>&nbsp;<\/p>\n<aside class=\"recommended pull pull--left sans-serif\" data-label=\"Related\"><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03164-5\" data-track=\"click\" data-track-label=\"recommended article\"><img decoding=\"async\" class=\"recommended__image\" src=\"https:\/\/media.nature.com\/w400\/magazine-assets\/d41586-019-03536-x\/d41586-019-03536-x_17391832.jpg\" \/><\/a><\/p>\n<p class=\"recommended__title serif\">Super-precise new CRISPR tool could tackle a plethora of genetic diseases<\/p>\n<\/aside>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Base editors can also be used to produce gene knockouts. The CRISPR\u2013Cas9 system is particularly adept at creating knockouts, thanks to the natural mechanism most commonly used to repair double-strand DNA breaks. That process can add or delete bases at the cut site, causing the gene sequence to be misread and causing protein synthesis to stop prematurely. But CBEs can convert certain codons \u2014 the three-base genetic words that define the sequence of amino acids in a protein \u2014 to a stop signal directly, an idea that researchers are exploiting to systematically test the effects of knocking out different genes across the genome<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR7\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">7<\/a><\/sup><sup>,<\/sup><sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR8\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">8<\/a><\/sup>. As base editors progress towards clinical trials, researchers have begun testing them in non-human primates. In unpublished work, Hui Yang, a developmental biologist at the Chinese Academy of Sciences in Shanghai, has applied base editors in mouse and monkey models of eye diseases, such as age-related macular degeneration, as well as Duchenne muscular dystrophy and Parkinson\u2019s disease. \u201cBase editors just cause single-strand breaks, not double-strand breaks, so I really think it\u2019s more safe than CRISPR,\u201d says Yang.<\/p>\n<p>Base editors could also be used to create high-yield or disease-resistant plant varieties, says Caixia Gao, a plant biologist at the Chinese Academy of Sciences in Beijing. \u201cA single nucleotide change can make some rice plants better use nitrogen in the field, for example,\u201d she says.<\/p>\n<p>&nbsp;<\/p>\n<p><b>Building a better editor<\/b><\/p>\n<p>Although theoretically similar to a genetic search-and-replace tool, base editors are in practice less precise.<\/p>\n<p>The fact that base editing uses Cas9 for sequence targeting means that it can produce off-target changes, just as CRISPR\u2013Cas9 does. But base-editor specificity is complicated further by the deaminases that actually alter the DNA. These enzymes can modify RNA and single-stranded DNA at sites other than the intended target<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR9\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">9<\/a><\/sup><sup>\u2013<\/sup><sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR11\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">11<\/a><\/sup>. \u201cWe don\u2019t know if these effects will be clinically relevant or not, but it\u2019s wise to try to minimize any unwanted editing,\u201d says Liu.<\/p>\n<p>ABEs apparently show no such off-target effects. This is probably because the ABE deaminase binds more weakly to its target than does the CBE deaminase, and so needs Cas9\u2019s help for efficient editing, says Liu. Researchers have now developed higher-fidelity CBEs, such as HF-BE3, with weaker target binding, and found that they have correspondingly lower levels of off-target editing<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR12\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">12<\/a><\/sup>.<\/p>\n<p>Base editors can also sometimes edit \u2018bystander\u2019 Cs or As that lie within their \u2018editing window\u2019 \u2014 the nucleotide region within which the enzyme works efficiently. Researchers have created editors with narrower or broader windows to enhance or reduce such effects. For instance, YE1-BE3 and YEE-BE3 are modified versions of BE3 with narrower activity windows<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR13\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">13<\/a><\/sup>, whereas ABE7.9<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR2\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">2<\/a><\/sup>\u00a0and the CBE BE-PLUS<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR14\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">14<\/a><\/sup>\u00a0have wider ones.<\/p>\n<aside class=\"recommended pull pull--left sans-serif\" data-label=\"Related\"><\/aside>\n<p>\u201cIf we think about genetic disease correction, we need to have very specific editing, where we need to have this activity window be very narrow, down to one nucleotide,\u201d says Gao. But an expanded editing window could be useful for accessing multiple target sites, for instance to introduce several point mutations at once.<\/p>\n<p>Base editors are also relatively limited in terms of the genomic sites that they can target; they can only act near a protospacer adjacent motif (PAM), the short DNA sequence required for successful binding of Cas9 to a DNA target. Because of that restriction, \u201cI believe only about 25% of the pathogenic mutations in the human genome can be precisely edited or corrected using current tools\u201d, says Huang. Researchers have expanded base editors\u2019 scope by using directed evolution to create Cas9 proteins that recognize a broader range of PAMs, and by fusing base editors to Cas9 variants with wider PAM compatibility.<\/p>\n<p>And then there is the issue of the limited range of base changes that editors can currently produce. To correct as many genetic diseases as possible, base editors will need to perform additional conversions, such as C to A, C to G, A to C and A to T. Jin-Soo Kim, a biochemist at the Institute for Basic Science in Daejeon, demonstrated this year that ABEs can achieve C-to-G conversion as well as C-to-T and A-to-G conversions in a human kidney cell line<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR15\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">15<\/a><\/sup>. \u201cThese results give us a hint on how to make other types of base editors,\u201d he says.<\/p>\n<p>Alternatively, researchers could use a new class of genome editors from Liu\u2019s lab, called prime editors, which can change any DNA base into any other<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR16\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">16<\/a><\/sup>. Prime editors use a special guide RNA template and Cas9 nickase to direct a reverse transcriptase enzyme to a target site. There, the enzyme makes a new DNA strand from the RNA template and inserts it at the target (see \u2018Prime corrective\u2019). But there are a lot of unknowns with these tools, \u201cincluding whether we can successfully do prime editing in animals and whether it will be as generalizable for many different types of cells as base editing\u201d, says Liu.<\/p>\n<p>&nbsp;<\/p>\n<figure class=\"figure\">\n<div class=\"embed intensity--high\">\n<div class=\"embed intensity--high\"><img decoding=\"async\" class=\"figure__image\" src=\"https:\/\/media.nature.com\/w800\/magazine-assets\/d41586-019-03536-x\/d41586-019-03536-x_17387400.jpg\" alt=\"\" data-src=\"\/\/media.nature.com\/w800\/magazine-assets\/d41586-019-03536-x\/d41586-019-03536-x_17387400.jpg\" \/><\/div>\n<\/div><figcaption>\n<p class=\"figure__caption sans-serif\">Source: Andrew Anzalone and David Liu<\/p>\n<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>With all these different options, researchers will need to consider their needs carefully to find the best fit for their project. For efficiently disrupting genes or inserting or replacing large DNA sequences, CRISPR\u2013Cas9 is the best bet, says Liu. It has been well studied, has lots of variants with greater specificity or particular PAM affinities, and is already being tested in clinical trials. Prime editors offer the greatest flexibility for creating DNA insertions, deletions, point mutations or combinations thereof. And base editors are ideal for correcting point mutations, providing higher efficiency and causing fewer indels.<\/p>\n<p>\u201cI think all three of these classes of genome-editing agents really have complementary strengths and weaknesses,\u201d says Liu. He likens CRISPR\u2013Cas9 to scissors, base editors to pencils, and prime editors to word processors. \u201cI think they all have their own roles in research and in applications such as agriculture and human therapeutics, just as scissors, pencils and word processors all have their own useful and unique roles.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p><b>As easy as CRISPR<\/b><\/p>\n<p>And just like scissors, pencils and word processors, base editing has been rapidly adopted by the scientific community, a testament to its low barrier to entry. \u201cIf you are familiar with genome-editing technology, I think you are ready to do base editing,\u201d says Kim.<\/p>\n<p>Researchers can order base editors from the non-profit plasmid repository Addgene. Liu recommends starting with some of the newest editors, such as his lab\u2019s BE4Max and ABEMax, which target C and A, respectively. But many others could also fit the bill, he adds, depending on the circumstances. (See Table 1 in ref. 17 for a good starting point.)<\/p>\n<p>Consider PAM specificity and the editing window required to access the target, Liu says. Consider also how much to prioritize reduced bystander editing or off-target effects. Specialized computational tools such as beditor can help researchers to design guide RNAs for their particular target.<\/p>\n<p>Still, base editors don\u2019t always work as expected. \u201cSometimes we have to test a couple of different editors before we find one that likes our target,\u201d says Komor. If nothing works, researchers can cut and paste from different base editors to make a custom editor, a process that Komor says is relatively straightforward. \u201cDon\u2019t be afraid to make your own.\u201d<\/p>\n<p>Whatever the editor, delivering them to cells requires standard genetic techniques, such as transfection, micro-injection and electroporation. \u201cYou can deliver them as protein\u2013RNA complexes, as mRNA or as DNA,\u201d says Liu. Therapeutic applications, however, will require a different approach.<\/p>\n<p>Conventional viral delivery vectors, such as adeno-associated virus (AAV), carry only limited genetic cargo, and base editors are typically too large to fit. \u201cOur current work is aimed at decreasing the size of the Cas9 and base editor, which I think will broaden its application,\u201d says Yang. Alternatively, researchers can split base editors across two vectors, as Kim did to target a mutation in the Duchenne muscular dystrophy gene in adult mice. \u201cWe were able to correct the mutation in skeletal muscle,\u201d he says<sup><a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29#ref-CR5\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">5<\/a><\/sup>.<\/p>\n<p>It is early days, but base editors have already become a promising addition to the genome-editing toolset. And they might have more tricks up their sleeves. Some editors, for instance, can act on RNA rather than DNA, opening up the possibility of knocking down or editing mRNA transcripts containing pathogenic mutations. Base editors might also be able to target mutations in mitochondria, which lack the DNA-repair pathways that conventional genome editing relies on, says Kim.<\/p>\n<p>For Gaudelli, such opportunities represent the realization of a lifelong dream. \u201cMy motivation for being in the sciences was to make a difference in the world,\u201d she says. \u201cI never thought it would be through base editing.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<p><span class=\"emphasis\">Nature<\/span>\u00a0<strong>575<\/strong>, 553-555 (2019)<\/p>\n<p>&nbsp;<\/p>\n<div class=\"emphasis\">doi: 10.1038\/d41586-019-03536-x<\/div>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>(\uc6d0\ubb38: <a href=\"https:\/\/www.nature.com\/articles\/d41586-019-03536-x?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+nature%2Frss%2Fcurrent+%28Nature+-+Issue%29\">\uc5ec\uae30<\/a>\ub97c \ud074\ub9ad\ud558\uc138\uc694~)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; A new class of CRISPR-based tools efficiently corrects point mutations in cell lines, animal models and perhaps the clinic. &nbsp; &nbsp; Credit: Getty<a href=\"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=4854\" class=\"more-link\">(more&#8230;)<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[33,34,29],"tags":[],"class_list":["post-4854","post","type-post","status-publish","format-standard","hentry","category-do-biology","category-lets-do-chemistry","category-lets-do-science"],"aioseo_notices":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack-related-posts":[{"id":3361,"url":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=3361","url_meta":{"origin":4854,"position":0},"title":"When genome editing goes off-target","author":"biochemistry","date":"April 19, 2019","format":false,"excerpt":"\u00a0 \u00a0 Editing DNA in eukaryotic cells with CRISPR-based systems has revolutionized the genome engineering field. Cas (CRISPR-associated) endonucleases are directed to a particular location in the genome by a short guide RNA, providing an easily programmable strategy to target any section of DNA. As of now, two CRISPR-based approaches\u2026","rel":"","context":"In &quot;Let's Do Biology!&quot;","block_context":{"text":"Let's Do Biology!","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?cat=33"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1313,"url":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=1313","url_meta":{"origin":4854,"position":1},"title":"Did CRISPR really fix a genetic mutation in these human embryos?","author":"biochemistry","date":"August 9, 2018","format":false,"excerpt":"\u00a0 \u00a0 (\uc6d0\ubb38) \u00a0 \u00a0 Researchers provide more evidence for their landmark claim that gene editing rid embryos of a disease mutation \u2014 but scientists are still arguing over the results. \u00a0 \u00a0 Eight-cell embryos injected with the gene editor CRISPR\u2013Cas9.Credit: H. Ma et al.\/Nature \u00a0 \u00a0 \u00a0 Biologists who\u2026","rel":"","context":"In &quot;Essays on Science&quot;","block_context":{"text":"Essays on Science","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?cat=32"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3625,"url":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=3625","url_meta":{"origin":4854,"position":2},"title":"Principles of and strategies for germline gene therapy","author":"biochemistry","date":"June 4, 2019","format":false,"excerpt":"\u00a0 \u00a0 Abstract Monogenic disorders occur at a high frequency in human populations and are commonly inherited through the germline. Unfortunately, once the mutation has been transmitted to a child, only limited treatment options are available in most cases. However, means of correcting disease-causing nuclear and mitochondrial DNA mutations in\u2026","rel":"","context":"In &quot;Let's Do Biology!&quot;","block_context":{"text":"Let's Do Biology!","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?cat=33"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2672,"url":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=2672","url_meta":{"origin":4854,"position":3},"title":"CRISPR-Cas9-Based Genome Editing of Human Cells","author":"biochemistry","date":"February 15, 2019","format":false,"excerpt":"\u00a0 \u00a0 CRISPR\/Cas9 systems are engineered versions of the Cas9 protein and guide RNA. \u00a0Typically, they are identical to the\u00a0Streptococcus pyogenes\u00a0type II CRISPR systems, except that a single guide-RNA is used in place of the complementary crRNAs and tracrRNAs of the natural CRISPR system, and the Cas9 protein is codon-optimized\u2026","rel":"","context":"In &quot;Let's Do Biology!&quot;","block_context":{"text":"Let's Do Biology!","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?cat=33"},"img":{"alt_text":"Genome Editing Overview2","src":"https:\/\/i0.wp.com\/sites.tufts.edu\/crispr\/files\/2014\/11\/Genome-Editing-Overview2-1024x667.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/sites.tufts.edu\/crispr\/files\/2014\/11\/Genome-Editing-Overview2-1024x667.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/sites.tufts.edu\/crispr\/files\/2014\/11\/Genome-Editing-Overview2-1024x667.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/sites.tufts.edu\/crispr\/files\/2014\/11\/Genome-Editing-Overview2-1024x667.png?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":2059,"url":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=2059","url_meta":{"origin":4854,"position":4},"title":"Towards therapeutic base editing","author":"biochemistry","date":"October 12, 2018","format":false,"excerpt":"\u00a0 \u00a0 \uc6d0\ubb38: \uc5ec\uae30\ub97c \ud074\ub9ad\ud558\uc138\uc694~ \u00a0 Base editors function in mouse fetuses and in the livers of adult mice to treat a genetic disorder. \u00a0 \u00a0 The vast majority of genetic diseases are caused by single-nucleotide mutations rather than chromosomal rearrangements or small insertions or deletions (indels) and hence could\u2026","rel":"","context":"In &quot;Let's Do Biology!&quot;","block_context":{"text":"Let's Do Biology!","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?cat=33"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2247,"url":"https:\/\/biochemistry.khu.ac.kr\/lab\/?p=2247","url_meta":{"origin":4854,"position":5},"title":"Precision genome engineering","author":"biochemistry","date":"December 3, 2018","format":false,"excerpt":"\u00a0 \u00a0 Genome editing through CRISPR-Cas systems has the potential to correct genetic mutations that occur in diseased cells, such as cancer cells. However, the ability to selectively activate CRISPR-Cas systems in diseased cells is important to ensure that gene editing only occurs where it is wanted. Zhu\u00a0et al.\u00a0developed a\u2026","rel":"","context":"In &quot;Let's Do Biology!&quot;","block_context":{"text":"Let's Do Biology!","link":"https:\/\/biochemistry.khu.ac.kr\/lab\/?cat=33"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":false,"jetpack_shortlink":"https:\/\/wp.me\/p9Xo1j-1gi","_links":{"self":[{"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=\/wp\/v2\/posts\/4854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4854"}],"version-history":[{"count":1,"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=\/wp\/v2\/posts\/4854\/revisions"}],"predecessor-version":[{"id":4855,"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=\/wp\/v2\/posts\/4854\/revisions\/4855"}],"wp:attachment":[{"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biochemistry.khu.ac.kr\/lab\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}